Biomarker Testing Market Forecast 2025–2034: Where Businesses Should Invest Next

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Biomarker Testing Market By 2029?

The biomarker testing market has experienced substantial growth recently. Its value is projected to increase from $17.51 billion in 2024 to $19.75 billion by 2025, at a compound annual growth rate (CAGR) of 12.8%. This past expansion can be linked to factors such as the greater acceptance of personalized medicine, the increased application of biomarkers in oncology, the growing prevalence of chronic diseases, enhanced research investment in life sciences, and a heightened need for early disease identification.

The biomarker testing market is set for substantial expansion in the coming years, with projections indicating it will reach $31.63 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.5%. This anticipated growth throughout the forecast period can be attributed to several factors, including the increasing application of biomarkers in non-oncology diseases, a surge in investment in companion diagnostics, the growing integration of artificial intelligence in diagnostic processes, the expanding use of point-of-care testing, and a rising awareness of preventive healthcare. Key trends during this period are expected to feature advancements in sequencing technologies, continuous innovations in liquid biopsy, the development of multiplex biomarker platforms, novel breakthroughs in proteomics and metabolomics, and significant investment in research and development.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24480&type=smp

Which Drivers Are Shaping The Biomarker Testing Industry’s Market Share?

The increasing prevalence of cancer is anticipated to fuel the expansion of the biomarker testing market moving forward. Cancer encompasses a range of illnesses characterized by the uncontrolled propagation and spread of atypical cells within the body. This escalating cancer burden stems from lifestyle factors such as inadequate nutrition, smoking, physical inactivity, and excessive alcohol intake. Biomarker testing enhances cancer detection by enabling the early and precise identification of disease-specific indicators, thereby improving diagnostic accuracy. It also supports personalized treatment regimens, leading to superior patient outcomes and more effective healthcare management. For instance, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that cancer cases diagnosed in Australia reached 160,570 in 2022, representing an increase of 3,789 cases from 156,781 in 2021. As a result, the rising incidence of cancer is a significant impetus for the growth of the biomarker testing market.

Which Key Segments Fueling The Biomarker Testing Market?

The biomarker testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments, Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies

3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents, Assay Kits, Sample Collection Devices, Chemicals And Buffers

2) By Instruments: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarray Systems, Mass Spectrometry Instruments, Immunoassay Analyzers

3) By Services: Biomarker Discovery Services, Diagnostic Testing Services, Companion Diagnostic Development, Clinical Trial Testing Services, Contract Research Organization (CRO) Services

Which Competitive Trends Are Defining The Biomarker Testing Market Structure?

Major entities engaged in the biomarker testing market are prioritizing the development of sophisticated solutions, such as immunohistochemistry (IHC) technology, to enhance diagnostic precision, enable early disease detection, and support individualized treatment plans. Immunohistochemistry (IHC) technology is a laboratory procedure that employs antibodies to detect specific proteins in tissue samples, aiding in the identification and visualization of biomarkers for disease diagnosis and research. For example, in July 2023, Quest Diagnostics Incorporated, a US-based medical laboratories company, launched a new tissue-based prostate cancer biomarker test through its AmeriPath business, aiming to improve diagnostic accuracy by utilizing proprietary biomarkers EV1, EV2, and EV3. This test addresses a significant clinical need by assisting physicians in more precisely identifying and differentiating aggressive forms of prostate cancer, improving grading consistency, and guiding appropriate treatment strategies for patients.

Which Key Players Are Driving Competition In The Biomarker Testing Market?

Major companies operating in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

How Do Regional Market Performances Compare Within The Biomarker Testing Industry?

North America was the largest region in the biomarker testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Biomarker Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24480&type=smp

Browse Through More Reports Similar to the Global Biomarker Testing Market 2025, By The Business Research Company

Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Clinical Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Biomarker Discovery Outsourcing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795